AzTrials
AzTrials

Neurodevelopmental DisordersNCT05584059

Pai.ACT Programme for Parents of Children With Special Healthcare Needs - Phase I

A study testing Focused Acceptance and Commitment Therapy in people with Neurodevelopmental Disorders and Attention Deficit Hyperactivity Disorder, run by Chinese University of Hong Kong at 5 sites in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to determine the feasibility, acceptability and potential efficacy of an individual, video-conferencing based Focused Acceptance and Commitment Therapy (FACT) on the mental well-being of parents of children with Special Health Care Needs(SHCN). Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Focused Acceptance and Commitment Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
5 sitesHong Kong
Study dates
1 Dec 2022to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Cantonese-speaking Hong Kong residents
  • living together with the child who is at preschool/school-age (3-9 years old)
  • adopt the responsibility of taking care of the child,
  • has daily access to their iPhone and Android smartphones.
  • In addition, potential eligible parents who respond "yes" to any of the five validated screening questions in the Children with Special Health Care Needs (SHCN) Screener (see https://www.childhealthdata.org/docs/cshcn/technical-summary-of-cshcn-screener.pdf) will then be asked the associated follow-up questions to determine whether the child possesses physical, neurodevelopmental/emotional problem(s) that has lasted for at least 12 months. Only children with a positive response(s) to ≥ 1 item in each of the associated follow-up questions will be classified as children with SHCN.

Who cannot join

  • Parents with severe mental illness or developmental disabilities which impaired their ability to comprehend the content of the programme will be excluded.

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Yuen Yu Chong, PhD contact

(852) 3943 0665

conniechong@cuhk.edu.hk

5 sites in 1 country

Hong Kong5 sites, 5 recruiting
  • Hong Kong Christian Service

    Hong Kong

    Jam Yau, jamyau@cuhk.edu.hk

    Recruiting
  • Hong Kong Federation of Youth Groups

    Hong Kong

    Jam Yau, jamyau@cuhk.edu.hk

    Recruiting
  • Hong Kong School Nurse Association

    Hong Kong

    Jam Yau, jamyau@cuhk.edu.hk

    Recruiting
  • Hong Kong Young Women's Christian Association

    Hong Kong

    Jam Yau, jamyau@cuhk.edu.hk

    Recruiting
  • Yang Memorial Methodist Social Service

    Hong Kong

    Jam Yau, jamyau@cuhk.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: Pai.ACT: A Deep-Learning Mental Health Advisory System Using Acceptance and Commitment Therapy for Parents of Children With Special Healthcare Needs (Phase I)

This study aims to determine the feasibility, acceptability and potential efficacy of an individual, video-conferencing based Focused Acceptance and Commitment Therapy (FACT) on the mental well-being of parents of children with Special Health Care Needs(SHCN). The study also aims to explore the experience of parents after participating in the individual-based FACT sessions offered by the trained FACT interventionists.

Read the detailed description

Parents of children with Special Health Care Needs (SHCN) have always been under tremendous pressure to care for their children. They have been experiencing significant caregiving difficulties, such as scheduling and accompanying multiple follow-ups for rehabilitation and functional recovery and managing the child's symptoms and problematic behaviours. With the strike of COVID-19, these parents' stress may even be exacerbated due to the lockdown measures. Children's needs become more demanding with the suspension of the usual care services. Parenting stress has been known to affect parent-child interactions and increase negative parenting behaviours such as harsh, permissive or neglecting parenting impairing the parent's capacity to respond to the demands of the child's illness, which may, in turn, exacerbate the child's health problem and well-being. Recent evidence has advocated the efficacy of Acceptance and Commitment Therapy (ACT) on mental health in different population groups, including healthy individuals, parents, children and those with mental health problems. To increase the reach of ACT and overcome the plausible disruptions of mental health services arising from the pandemic, the study proposes to use an innovative intervention approach, that is a brief version of ACT (Focused ACT), delivered by trained FACT interventionists in individual-based, video-conferencing format. The conversation data between the parent and the interventionist will be further analyzed for developing a Deep-Learning Mental Health Advisory System in the second phase of the Pai.ACT project. This study aims to determine the feasibility, acceptability and potential efficacy of an individual, video-conferencing-based Focused Acceptance and Commitment Therapy (FACT) on the mental well-being of parents of children with Special Health Care Needs(SHCN). The study also aims to explore the experience of parents after participating in the individual-based FACT sessions offered by the trained FACT interventionists.

Being tested
Focused Acceptance and Commitment Therapy
Keywords
Focused Acceptance and Commitment Therapy, Special health care needs, Mobile App, Machine Learning
Medical subject headings
Neurodevelopmental Disorders, Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder, Learning Disabilities, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focused Acceptance and Commitment TherapyBehavioural

    This is an individual-based FACT counselling programme which composes of 4-6 sessions on a weekly basis (45-60mins/session). All the sessions are delivered by a trained FACT interventionist via either video-conferencing (e.g., Zoom or Windows Teams) or face-to-face format. The programme aims to increase the psychological flexibility of the parent, so that he/she is able to (i) experience the present moment and take perspective on self (i.e., Awareness); (ii) detach the distressing private experiences and associated rules and to take a non-judgemental, accepting stance toward the painful experiences (i.e., Openness) and (iii) exhibits strong connection with values and commit to values-consistent actions. The trained interventionist will use different ACT strategies in these sessions, including ACT metaphors, experiential exercises, guided mindfulness exercises, guided imagery exercises and values clarification exercises to reinforce the above principles.

Study groups in NCT05584059
Study groupRoleWhat they receive
FACT GroupExperimental4-6 weeks of 45-60 minute individual-based Focused Acceptance and Commitment Therapy (FACT) counselling sessions delivered via video-conferencing format or face-to-face
Receives: Behavioral: Focused Acceptance and Commitment Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parental depressive symptoms

    The Patient Health Questionnaire (PHQ-9, 9-item, 4-point Likert scale) will be used to assess the frequency of the parents experiencing depressive symptoms in the past two weeks. The Chinese version of the PHQ-9 has demonstrated good internal consistency reliability (Cronbach's alpha = 0.86) and a 2-week test-retest correlation coefficient.

    Measured: Change from baseline assessment to immediate post-assessment

  2. Parental anxiety symptoms

    The Generalized Anxiety Disorder-7 (GAD-7, 7-item, 4-point Likert scale) will be used to measure the severity of anxiety symptoms. The Chinese version of the GAD-7 demonstrated good reliability and validity with a Cronbach's coefficient of 0.91.

    Measured: Change from baseline assessment to immediate post-assessment

  3. Parental Stress

    The Parental Stress Scale (PSS, 16-item, 5-point scale) will be used to assess parenting stress. A higher score represents a higher level of parental stress. The Chinese version of the PSS has demonstrated acceptable psychometric properties and is therefore suitable for use by researchers to assess the parental stress levels of Chinese parents.

    Measured: Change from baseline assessment to immediate post-assessment

Secondary outcomes (1)
  1. Parental Psychological Flexibility

    The PsyFlex (6-item 5-point Likert Scale) will assess all the six therapeutic processes of Acceptance and Commitment Therapy (ACT). Each item refers to one of the core skills that ACT focuses on when developing psychological flexibility and well-being. The score is then interpreted such that higher scores represent higher psychological flexibility.

    Measured: Change from baseline assessment to immediate post-assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2022
  2. Study start1 Dec 2022
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05584059
Sponsor's protocol ID
ITB/FBL/6033/21/P
Status last verified
Aug 2025
First submitted
14 Oct 2022
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Focused Acceptance and Commitment Therapy in people with Neurodevelopmental Disorders and Attention Deficit Hyperactivity Disorder, run by Chinese University of Hong Kong at 5 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yuen Yu Chong, PhD ((852) 3943 0665, conniechong@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parental depressive symptoms (time frame: Change from baseline assessment to immediate post-assessment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in